The cell cycle can be a new target for the treatment of cardiac hypertrophy?

J Mol Cell Cardiol. 2001 Oct;33(10):1769-71. doi: 10.1006/jmcc.2001.1449.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • 3T3 Cells
  • Adenoviridae / genetics
  • Animals
  • Cardiomegaly / therapy*
  • Cell Cycle / physiology*
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Heart Diseases / etiology
  • Humans
  • Mice
  • Mutation
  • Phosphorylation
  • Risk Factors

Substances

  • Cyclin-Dependent Kinase Inhibitor p16